Mar 15, 2023 08:00AM
Jan 24, 2023 09:45AM
Oct 27, 2022 05:00PM
Oct 21, 2022 05:42PM
Oct 17, 2022 03:33PM
Oct 17, 2022 03:30PM
Oct 6, 2022 06:10PM Statera Biopharma Completes Fiscal 2021 Audit; Files Form 10-K
Sep 12, 2022 05:28AM
Sep 9, 2022 07:50PM
Aug 25, 2022 05:30PM
May 23, 2022 04:07PM
May 23, 2022 04:05PM
May 23, 2022 04:05PM
May 13, 2022 07:31AM Statera Biopharma (STAB) and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products
May 13, 2022 07:30AM
May 13, 2022 07:30AM
Apr 27, 2022 04:11PM
Apr 27, 2022 04:10PM
Apr 27, 2022 04:10PM
Apr 22, 2022 05:26PM
Apr 22, 2022 05:26PM Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing
Apr 13, 2022 04:06PM
Apr 13, 2022 04:05PM
Apr 13, 2022 04:05PM
Apr 13, 2022 09:15AM
Apr 13, 2022 07:01AM
Apr 13, 2022 07:00AM
Mar 8, 2022 04:15PM Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021
Mar 8, 2022 04:15PM
Feb 22, 2022 07:52AM
Feb 22, 2022 07:51AM
Feb 22, 2022 07:51AM
Dec 29, 2021 07:32AM
Dec 29, 2021 07:32AM
Dec 29, 2021 07:32AM Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease
Dec 20, 2021 04:03PM
Dec 20, 2021 04:03PM
Dec 1, 2021 07:32AM
Dec 1, 2021 07:32AM
Dec 1, 2021 07:32AM
Nov 15, 2021 04:03PM
Nov 15, 2021 04:03PM Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update
Nov 9, 2021 07:32AM
Nov 9, 2021 07:32AM
Nov 1, 2021 07:32AM
Nov 1, 2021 07:32AM
Oct 19, 2021 07:32AM
Oct 19, 2021 07:32AM
Oct 6, 2021 07:33AM Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference
Oct 6, 2021 07:33AM

1,156,756 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All